Wealth Enhancement Advisory Services LLC trimmed its stake in shares of Molina Healthcare, Inc (NYSE:MOH – Free Report) by 13.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 13,485 shares of the company’s stock after selling 2,150 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Molina Healthcare were worth $4,017,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of the stock. Rothschild Investment LLC grew its position in shares of Molina Healthcare by 126.3% during the first quarter. Rothschild Investment LLC now owns 86 shares of the company’s stock valued at $28,000 after purchasing an additional 48 shares in the last quarter. Zions Bancorporation National Association UT purchased a new position in Molina Healthcare during the 1st quarter valued at approximately $29,000. Deseret Mutual Benefit Administrators increased its stake in Molina Healthcare by 60.7% in the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company’s stock worth $30,000 after acquiring an additional 34 shares during the last quarter. Elequin Capital LP raised its holdings in shares of Molina Healthcare by 170.6% during the 1st quarter. Elequin Capital LP now owns 92 shares of the company’s stock worth $30,000 after acquiring an additional 58 shares in the last quarter. Finally, Silver Oak Securities Incorporated bought a new position in shares of Molina Healthcare during the 1st quarter valued at approximately $34,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.
Insider Activity
In related news, COO James Woys bought 10,000 shares of the stock in a transaction on Monday, August 4th. The stock was bought at an average price of $155.94 per share, for a total transaction of $1,559,400.00. Following the completion of the acquisition, the chief operating officer directly owned 74,331 shares in the company, valued at approximately $11,591,176.14. This represents a 15.54% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Ronna Romney sold 700 shares of the business’s stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total value of $107,618.00. Following the completion of the transaction, the director directly owned 17,131 shares of the company’s stock, valued at approximately $2,633,719.94. The trade was a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.
Molina Healthcare Price Performance
Molina Healthcare (NYSE:MOH – Get Free Report) last announced its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.50 by ($0.02). Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The firm had revenue of $11.43 billion during the quarter, compared to the consensus estimate of $10.94 billion. During the same period last year, the company earned $5.86 EPS. The firm’s revenue for the quarter was up 15.7% compared to the same quarter last year. On average, research analysts forecast that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.
Wall Street Analyst Weigh In
MOH has been the topic of several research reports. Sanford C. Bernstein reduced their price target on shares of Molina Healthcare from $284.00 to $220.00 and set an “outperform” rating on the stock in a research report on Friday, September 5th. Cantor Fitzgerald reissued a “neutral” rating and issued a $210.00 price objective on shares of Molina Healthcare in a research note on Tuesday, August 26th. JPMorgan Chase & Co. decreased their target price on shares of Molina Healthcare from $272.00 to $184.00 and set a “neutral” rating on the stock in a research report on Tuesday, July 29th. Robert W. Baird lowered their price target on shares of Molina Healthcare from $373.00 to $179.00 and set a “neutral” rating for the company in a report on Friday, July 25th. Finally, Barclays reduced their price objective on Molina Healthcare from $186.00 to $185.00 and set an “equal weight” rating on the stock in a research note on Thursday, September 4th. Three research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $225.18.
View Our Latest Analysis on Molina Healthcare
Molina Healthcare Profile
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Read More
- Five stocks we like better than Molina Healthcare
- Roth IRA Calculator: Calculate Your Potential Returns
- Lower Rates Put RV Stocks Back in the Fast Lane
- How to Plot Fibonacci Price Inflection Levels
- Alphabet: Time to Take Profits, Buy, or Wait for a Pullback?
- Following Congress Stock Trades
- Hershey vs. Mondelez: Which Stock Wins Chocolate Season?
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.